2003
CMS Decision Leaves Some Seniors Without Coverage for Now Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that an arbitration panel entered a preliminary finding that...
International Symposium Offers Unique Opportunity for Experts in Device and Drug Therapies to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored by...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
New Trial Signifies Continued Leadership in Heart Failure Clinical Science Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Guidant's Institute for Therapy Advancement - Japan Continues Leadership in Medical Education Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
State-of-the-Art Simulation Programs Expand Guidant''s Medical Education Offerings to Physicians Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the...
Meeting to be held in Indianapolis on May 19 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
New Indication Allows Physicians to Harvest Artery in Arm For Coronary Bypass Graft Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the...
Landmark Trials Featured Indianapolis, Ind. and St. Paul, Minn. - Two Guidant Corporation (NYSE: GDT) sponsored clinical trials will be prominently featured during the 24th annual meeting of the...
Establishment of New DRG 535 is Milestone in Advancement of Heart Failure Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an...
Guidant Announces CE Mark and First Implant of Newest Cardiac Resynchronization Pacemaker
The CONTAK RENEWAL TR 2 Implantable Cardiac Resynchronization Therapy Pacemaker Offers Market-leading Diagnostics and Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:...
New Device Captures Emboli Released During Carotid Stenting Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
Results Presented at American Association of Thoracic Surgeon''s 83rd Annual Meeting Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Strategic Alliance Aimed at Expanding Options for the Treatment of Sleep-Disordered Breathing Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham, Advisor to the President, has elected...
Worldwide Implantable Defibrillator Revenue Growth of 72 Percent Changes Product Mix Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE:...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2003 earnings conference...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Guidant will acquire an early-stage company founded by...
VITALITY AVT Implantable Defibrillator Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Preliminary Data Demonstrate Mortality Benefit and Reduced Hospitalization for Heart Failure Patients CHICAGO - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Limited European and Australian Accounts Affected Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has...